國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Alzheimer's disease theranostics

Obulesu, Magisetty.

Alzheimer's disease theranostics

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Alzheimer's disease theranosticsMagisetty Obulesu.
作者:	Obulesu, Magisetty.
出版者:	London :Elsevier,2019.
面頁冊數:	1 online resource.
標題:	Alzheimer's disease.
電子資源:	https://www.sciencedirect.com/science/book/9780128164129
ISBN:	9780128167397 (electronic bk.)

Alzheimer's disease theranostics
Obulesu, Magisetty.

Alzheimer's disease theranostics[electronic resource] /Magisetty Obulesu. - London :Elsevier,2019. - 1 online resource.

Includes bibliographical references and index.

Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS

ISBN: 9780128167397 (electronic bk.)Subjects--Topical Terms:

229397
Alzheimer's disease.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RC523

Dewey Class. No.: 616.831

National Library of Medicine Call No.: 2019 C-919

Alzheimer's disease theranostics
LDR:03894cmm a2200325 a 4500 001 601632
006 m o d
007 cr cnu---unuuu
008 211110s2019 enka gob 001 0 eng d
020 $a 9780128167397 (electronic bk.)
020 $a 0128167394 (electronic bk.)
020 $a 9780128164129
020 $a 0128164123
035 $a (OCoLC)1083460118
035 $a on1083460118
040 $a YDX $b eng $c YDX $d N $d EBLCP $d OPELS $d OCLCF $d OCLCQ $d DKU $d OCLCO $d OCLCQ $d S2H $d OCLCO $d UX1 $d VT2 $d OCLCA
041 0 $a eng
050 4 $a RC523
060 0 0 $a 2019 C-919
060 1 0 $a WT 155
082 0 4 $a 616.831 $2 23
100 1 $a Obulesu, Magisetty. $3 896970
245 1 0 $a Alzheimer's disease theranostics $h [electronic resource] / $c Magisetty Obulesu.
260 $a London : $b Elsevier, $c 2019.
300 $a 1 online resource.
504 $a Includes bibliographical references and index.
505 0 $a Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS
505 8 $a BIOMARKERSBlood Biomarkers; Protein Biomarkers; MIRNA; GLUCOSE LEVELS; CONCLUSION; REFERENCES; 3 -- Antioxidants in Alzheimer's Therapy; ABSTRACT; KEYWORDS; INTRODUCTION; ANTIOXIDANTS; Plant Extracts; Withanolides; NEUROINFLAMMATION-TARGETED THERAPEUTICS; Antioxidant Enzymes; Limitations; MELATONIN; LIPOIC ACID; NANOTECHNOLOGY; CONCLUSION; REFERENCES; 4 -- Natural Products in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; FLAVONOIDS; Epigallocatechin-3-Gallate; RESVERATROL; SAIKOSAPONINS; CURCUMIN; CLICK CHEMISTRY; NANOTECHNOLOGY; CHITOSAN; CONCLUSION; REFERENCES
505 8 $a 5 -- Blood-Brain Barrier-Targeted Nanotechnological AdvancesABSTRACT; KEYWORDS; INTRODUCTION; PHYSIOLOGY; PATHOLOGY; BCSFB; THERAPEUTICS; Matrix Metalloproteinases; Nanoparticles; Gold nanoparticles; Liposomes; Magnetic nanoparticles; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 6 -- Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; PRESENILIN; STEM CELLS; MICRORNA/CDK5R1; HEAT SHOCK PROTEIN; BECLIN; APOLIPOPROTEIN E; DRUG MECHANISM/GENE MODIFICATION; NEUROINFLAMMATION AND CYTOKINES; CONCLUSION; REFERENCES
505 8 $a 7 -- Viral Vector Therapeutics Against Alzheimer's DiseaseABSTRACT; KEYWORDS; INTRODUCTION; Viral Vector Therapeutics; Adeno-Associated Viral Vectors; mAbs; Tau; PROGRANULIN; NEPRILYSIN; GENE-BASED IMMUNOTHERAPEUTIC METHODS; CONCLUSION; REFERENCES; 8 -- Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; Nanoparticles; Flurbiprofen Nanoparticles; Nattokinase Nanoparticles; Intranasal Delivery; Triphenylphosphonium Functionalization; Cerium Oxide Nanoparticles; CONCLUSION; REFERENCES
505 8 $a 9 -- Nanoparticles: The Double-Edged SwordsABSTRACT; KEYWORDS; INTRODUCTION; Nanotechnology; Polymeric Materials; Carbon Nanotubes; Hydrogels; Tissue Engineering Scaffolds; Delivery Systems for Growth Factors; Delivery Systems for Chelators; DEMERITS OF BIOMATERIALS; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 10 -- Alzheimer Therapeutics: Pros and Cons; ABSTRACT; KEYWORDS; INTRODUCTION; Neuroinflammation and Cytokines; Demerits; Antioxidants; Shortcomings; DRUG MECHANISM/GENE MODIFICATION; Neprilysin; Limitations; Nanotechnology; Gold Nanoparticles; Liposomes; Magnetic Nanoparticles
650 0 $a Alzheimer's disease. $3 229397
650 2 $a Alzheimer Disease. $3 229400
650 2 $a Theranostic Nanomedicine. $3 896971
650 7 $a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh $3 571422
650 7 $a MEDICAL $x Clinical Medicine. $2 bisacsh $3 537581
650 7 $a MEDICAL $x Diseases. $2 bisacsh $3 571423
650 7 $a MEDICAL $x Evidence-Based Medicine. $2 bisacsh $3 571676
650 7 $a MEDICAL $x Internal Medicine. $2 bisacsh $3 571677
655 0 $a Electronic books. $2 local. $3 214472
856 4 0 $u https://www.sciencedirect.com/science/book/9780128164129